Cagrilintide
Cagrilintide
Cagrilintide is a synthetic peptide that acts as an amylin analog. It is being investigated for its potential use in the treatment of obesity and type 2 diabetes. Cagrilintide is designed to mimic the effects of the naturally occurring hormone amylin, which is co-secreted with insulin by the pancreatic beta cells.
Mechanism of Action[edit | edit source]
Cagrilintide works by mimicking the action of amylin, a hormone that helps regulate blood glucose levels and suppress appetite. Amylin slows gastric emptying, reduces postprandial glucagon secretion, and promotes satiety. By acting as an amylin analog, cagrilintide can help control blood sugar levels and reduce food intake, which may aid in weight loss and improve glycemic control in individuals with type 2 diabetes.
Clinical Development[edit | edit source]
Cagrilintide is currently undergoing clinical trials to evaluate its safety and efficacy. It is being studied both as a monotherapy and in combination with other antidiabetic agents. The results of these trials will determine its potential role in the management of obesity and type 2 diabetes.
Potential Benefits[edit | edit source]
The potential benefits of cagrilintide include improved glycemic control, weight loss, and reduced risk of cardiovascular complications associated with obesity and type 2 diabetes. By enhancing the effects of amylin, cagrilintide may offer a novel therapeutic option for patients who are unable to achieve adequate control with existing treatments.
Side Effects[edit | edit source]
As with any medication, cagrilintide may have side effects. Common side effects observed in clinical trials include nausea, vomiting, and decreased appetite. The safety profile of cagrilintide is still being evaluated, and further studies are needed to fully understand its long-term effects.
Related Pages[edit | edit source]
This peptide related article is a stub. You can help WikiMD by expanding it.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD